18 Results

People

  1. Heller
    Heller
  2. Van Den Brink
    Van Den Brink
  3. Alpdogan
    Alpdogan
  4. Kochman
    Kochman
  5. Eng
    Eng
  6. Hubbard
    Hubbard
  7. Lu
    Lu
  8. Suh
    Suh
  9. Grubin
    Grubin
  10. Kim
    Kim

Groups

  1. Biostatistics Service (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Epidemiology and Biostatistics (18)
  5. GSK Faculty (18)
  6. Hematologic Malignancies, Division of (18)
  7. Sloan Kettering Institute Faculty (18)
  8. Immunology Program Faculty (15)
  9. Executive Committee, Center for Hematologic Malignancies (13)
  10. Molecular Pharmacology and Chemistry Program Faculty (8)
  1. "nonhuman"
  2. "Center for Hematologic Malignancies"
  3. "Sloan Kettering Institute Faculty"
  4. "Journal article"
  5. "Glenn Heller"
Formats
  1. Journal Article (18)
Groups
  1. Biostatistics Service (18)
  2. Center for Hematologic Malignancies (18)
  3. Department of Medicine (18)
  4. Epidemiology and Biostatistics (18)
  5. GSK Faculty (18)
  6. Hematologic Malignancies, Division of (18)

More Groups

People
  1. Glenn Heller (18)
  2. Marcel Van Den Brink (13)
  3. Adam Kochman (8)
  4. Seyfettin Alpdogan (8)
  5. Theis Terwey (7)
  6. David Suh (6)

More People

Years
  1. 2014 (1)
  2. 2011 (1)
  3. 2010 (3)
  4. 2009 (1)
  5. 2008 (2)
  6. 2007 (1)

More Years

Publications
  1. Blood (10)
  2. Journal of Immunology (2)
  3. Nature Biotechnology (2)
  4. Cancer Research (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Nature (1)

More Publications

Publishers
  1. American Society of Hematology (10)
  2. Nature Publishing Group (4)
  3. The American Association of Immunologists, Inc (2)
  4. American Association for Cancer Research (1)
  5. Oxford University Press (1)

Results (18)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Safe mobilization of CD34+ cells in adults with β-thalassemia and validation of effective globin gene transfer for clinical investigation
    Journal Article

    Boulad, F.; Wang, X.; Qu, J.; Taylor, C.; Ferro, L.; Karponi, G.; Bartido, S.; Giardina, P.; Heller, G.; Prockop, S. E.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • In vivo inhibition of human CD19-targeted effector T cells by natural T regulatory cells in a xenotransplant murine model of B cell malignancy
    Journal Article

    Lee, J. C.; Hayman, E.; Pegram, H. J.; Santos, E.; Heller, G.; Sadelain, M.; Brentjens, R.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth
    Journal Article

    Penack, O.; Henke, E.; Suh, D.; King, C. G.; Smith, O. M.; Na, I. K.; Holland, A. M.; Ghosh, A.; Lu, S. X.; Jenq, R. R.; more...
    JNCI: Journal of the National Cancer Institute (2010)

    Fulltext@MSK | Save
  • Response: Sample size and statistical comparisons of GVHD rates in pediatric Niemann-Pick disease patients
    Journal Article

    Kolesnick, R.; Van Den Brink, M.; Heller, G.; Rotolo, J. A.
    Blood (2010)

    Fulltext@MSK | Save
  • An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment
    Journal Article

    Eldjerou, L. K.; Chaudhury, S.; Baisre-de Leon, A.; He, M.; Arcila, M. E.; Heller, G.; O'Reilly, R. J.; Barker, J. N.; Moore, M. A.
    Blood (2010)

    Fulltext@MSK | Save
  • IL-17 contributes to CD4-mediated graft-versus-host disease
    Journal Article

    Kappel, L. W.; Goldberg, G. L.; King, C. G.; Suh, D. Y.; Smith, O. M.; Ligh, C.; Holland, A. M.; Grubin, J.; Mark, N. M.; Liu, C.; more...
    Blood (2009)

    Fulltext@MSK | Save
  • Tumor immunotherapy across MHC barriers using allogeneic T-cell precursors
    Journal Article

    Zakrzewski, J. L.; Suh, D.; Markley, J. C.; Smith, O. M.; King, C.; Goldberg, G. L.; Jenq, R.; Holland, A. M.; Grubin, J.; Cabrera-Perez, J.; more...
    Nature Biotechnology (2008)

    Fulltext@MSK | Save
  • Organ-derived dendritic cells have differential effects on alloreactive T cells
    Journal Article

    Kim, T. D.; Terwey, T. H.; Zakrzewski, J. L.; Suh, D.; Kochman, A. A.; Chen, M. E.; King, C. G.; Borsotti, C.; Grubin, J.; Smith, O. M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • IFN-γ and Fas ligand are required for graft-versus-tumor activity against renal cell carcinoma in the absence of lethal graft-versus-host disease
    Journal Article

    Ramirez-Montagut, T.; Chow, A.; Kochman, A. A.; Smith, O. M.; Suh, D.; Sindhi, H.; Lu, S.; Borsotti, C.; Grubin, J.; Patel, N.; more...
    Journal of Immunology (2007)

    Fulltext@MSK | Save
  • Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation
    Journal Article

    Zakrzewski, J. L.; Kochman, A. A.; Lu, S. X.; Terwey, T. H.; Kim, T. D.; Hubbard, V. M.; Muriglan, S. J.; Suh, D.; Smith, O. M.; Grubin, J.; more...
    Nature Medicine (2006)

    Fulltext@MSK | Save